DexCom, Inc. (DXCM)

66.96 -1.98 (-2.87%) USD  |  NASDAQ  |  Dec 12, 16:00
66.85 -0.11 (-0.16%) After-Hours: 20:00
More

DexCom EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Abbott Laboratories --
BioLife Solutions, Inc. --
Eli Lilly & Co. --
Sotera Health Co. --
Regeneron Pharmaceuticals, Inc. --